Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Videos

What did we learn in IAVI G001?

February 3, 2021

It all began with the mission to accelerate the development of safe, effective AIDS vaccines for use throughout the world. Today, we remain dedicated to our search for an HIV vaccine, while applying all that we have learned to translate scientific discoveries into affordable, globally accessible public health solutions for other major challenges. In 2021, as IAVI turned 25, we reflected on all we and our partners have accomplished and what the future holds for IAVI and global health research.

Read more

Press Releases

First-in-human clinical trial confirms novel HIV vaccine approach developed by IAVI and Scripps Research

February 3, 2021

The experimental vaccine primed the immune system as the first stage in the production of broadly neutralizing antibodies.

Read more

Features

Evolving access pathways for long-acting HIV prevention products

February 3, 2021

Exploring potential bottlenecks and providing recommendations to accelerate access to future HIV prevention products.

Read more

Features

IAVI Remembers Philip Russell, Vaccine Scientist, Global Health Leader

February 2, 2021

IAVI is saddened by the passing of Philip Russell, M.D., a committed global health leader and founding member of this organization.

Read more

Features

UPDATED: IAVI Sees Hope in Findings of Antibody-Mediated Prevention Study

January 26, 2021

Results illuminate potential way forward for use of broadly neutralizing antibodies to prevent HIV.

Read more

In The News

Merck Scraps Covid-19 Vaccine Candidates

The Wall Street Journal

January 25, 2021

Read more

In The News

Merck Abandons Vaccines in Two Clinical Trials

The New York Times

January 25, 2021

Read more

In The News

In a major setback, Merck to stop developing its two Covid-19 vaccines and focus on therapies

STAT News

January 25, 2021

Read more